ImmunoPrecise Antibodies (IPA) to Release Quarterly Earnings on Friday

ImmunoPrecise Antibodies (NASDAQ:IPA) is projected to release its earnings data before the market opens on Friday, March 28th. Analysts expect ImmunoPrecise Antibodies to post earnings of ($0.06) per share and revenue of $6.59 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

ImmunoPrecise Antibodies Trading Up 1.5 %

ImmunoPrecise Antibodies stock opened at $0.45 on Friday. The company has a 50 day moving average price of $0.45 and a 200 day moving average price of $0.49. ImmunoPrecise Antibodies has a 52 week low of $0.27 and a 52 week high of $1.64. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.85 and a current ratio of 1.01. The firm has a market capitalization of $13.87 million, a price-to-earnings ratio of -0.57 and a beta of 0.09.

Analyst Upgrades and Downgrades

Separately, HC Wainwright restated a “buy” rating and set a $7.00 price target on shares of ImmunoPrecise Antibodies in a report on Friday, March 14th.

ImmunoPrecise Antibodies Company Profile

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, a positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes.